Novel one step RT-PCR methods, enzyme mixes and kits for use in practicing the same

Abstract

Enzyme compositions, kits comprising the same and methods for their use in one-step RT-PCR are provided. The subject enzyme compositions at least include a mutant thermostable DNA polymerase and a mutant reverse transcriptase. In preferred embodiments, the mutant thermostable DNA polymerase is an N-terminal deletion mutant of Taq polymerase and the mutant reverse transcriptase is a point mutation mutant of MMLV-RT. The subject kits, in addition to the above described mutant thermostable DNA polymerase and mutant reverse transcriptase, at least include one of, and usually both of, dNTPs and a buffer composition, where the subject kits may further include additional reagents, including nucleic acids, a thermostabilizing agent, a glycine based osmolyte and the like. In practicing the subject methods, a reaction mix that at least includes template RNA, the above described mutant polymerase and reverse transcriptase, dNTPs, buffer, and nucleic acid primers is prepared. The resultant reaction mixture is maintained at a first set of reverse transcription conditions and then a second set of PCR conditions, whereby amplified amounts of DNA from a template RNA(s) are produced.

What is claimed is:  
     
         1 . An enzyme composition comprising: 
 a mutant thermostable DNA polymerase; and    a mutant reverse transcriptase.    
     
     
         2 . The enzyme composition according to  claim 1 , wherein said mutant DNA polymerase is a mutant Taq polymerase.  
     
     
         3 . The enzyme composition according to  claim 2 , wherein said mutant Taq polymerase is a deletion mutant.  
     
     
         4 . The enzyme composition according to  claim 3 , wherein said deletion mutant is an N-terminal deletion mutant.  
     
     
         5 . The enzyme composition according to  claim 1 , wherein said mutant reverse transcriptase is a mutant of moloney murine leukemia virus reverse transcriptase.  
     
     
         6 . The enzyme composition according to  claim 5 , wherein said mutant is a point mutation mutant.  
     
     
         7 . The enzyme composition according to  claim 6 , wherein said mutant exhibits substantially the same RT activity as wild type moloney murine leukemia virus reverse transcriptase.  
     
     
         8 . The enzyme composition according to  claim 1 , wherein said enzyme composition further comprises an antibody specific for said mutant thermostable DNA polymerase.  
     
     
         9 . An enzyme composition comprising: 
 an N-terminal deletion mutant of Taq polymerase;    a point mutation mutant of moloney murine leukemia virus reverse transcriptase; and    an antibody specific for said N-terminal deletion mutant of Taq polymerase.    
     
     
         10 . The enzyme composition according to  claim 9 , wherein the ratio of said mutant Taq polymerase mutant to said reverse transcriptase mutant ranges from about 0.8 to 6.5.  
     
     
         11 . The enzyme composition according to  claim 9 , wherein the amount of said antibody in said composition ranges from about 0.9 to 1.1 μg.  
     
     
         12 . A kit for use in a one step nucleic acid amplification procedure, said kit comprising: 
 (a) a mutant thermostable DNA polymerase;    (b) a mutant reverse transcriptase; and    (b) at least one of the following components: 
 (i) dNTPs; and  
 (ii) buffer.  
   
     
     
         13 . The kit according to  claim 12 , wherein said kit further includes a thermostabilizing agent.  
     
     
         14 . The kit according to  claim 12 , wherein said kit further includes a glycine based osmolyte.  
     
     
         15 . The kit according to  claim 12 , wherein said kit further includes at least one nucleic acid.  
     
     
         16 . The kit according to  claim 12 , wherein said kit further includes an RNase inhibitor.  
     
     
         17 . A method for producing an amplified amount of DNA from a template RNA, said method comprising: 
 (a) preparing an aqueous reaction mixture comprising: 
 (i) said RNA template;  
 (ii) a mutant thermostable DNA polymerase;  
 (iii) a mutant reverse transcriptase;  
 (iv) dNTPs  
 (v) buffer reagents; and  
 (vi) at least one nucleic acid primer;  
   (b) subjecting said reaction mixture at a first set of reverse transcription reaction conditions suitable for reverse transcription of said RNA template into cDNA; and    (c) subjecting said reaction mixture at a second set of PCR conditions suitable for amplification of said cDNA;    whereby an amplified amount of DNA is produced from a template RNA.    
     
     
         18 . The method according to  claim 17 , wherein said reaction mixture further includes an antibody specific for said mutant thermostable polymerase.  
     
     
         19 . The method according to  claim 17 , wherein said reaction mixture further comprises a glycine based osmolyte.  
     
     
         20 . The method according to  claim 17 , wherein said reaction mixture further comprises a thermostabilizing reagent.  
     
     
         21 . The method according to  claim 17 , wherein mutant thermostable polymerase is an N-terminal deletion mutant of Taq polymerase.  
     
     
         22 . The method according to  claim 17 , wherein said mutant reverse transcriptase is a point mutation mutant of moloney murine leukemia virus reverse transcriptase.